✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Glecaprevir

Glecaprevir

CAS 1365970-03-1C38H46F4N6O9SMW 838.9

Glecaprevir (CAS 1365970-03-1) — formula C38H46F4N6O9S, molecular weight 838.9; category organic chemicals.

Product Overview

CAS Number1365970-03-1
Molecular FormulaC38H46F4N6O9S
Molecular Weight838.9
LogP4.6
CategoryOrganic Chemicals

Technical Profile

What this product is

Glecaprevir is a carbon-based organic compound with CAS registry number 1365970-03-1 and molecular formula C38H46F4N6O9S (molecular weight 838.9), belonging to the organic chemicals segment of chemical raw materials.

Identification

CAS number: 1365970-03-1

Its molecular formula C38H46F4N6O9S comprises 38 C, 46 H, 4 F, 6 N, 9 O, 1 S atoms.

Also known as: Glecaprevir · 格卡瑞韦

Category: organic chemicals

Frequently Asked Questions

What is the CAS number of Glecaprevir?

The CAS registry number of Glecaprevir is 1365970-03-1.

What is the molecular formula and molecular weight of Glecaprevir?

Molecular formula C38H46F4N6O9S, molecular weight 838.9.

What other names is Glecaprevir known by?

It is also registered under: Glecaprevir, 格卡瑞韦.

Which category does Glecaprevir belong to?

Category: Organic Chemicals.

PubChem Public Data

Independent reference data for Glecaprevir (CAS 1365970-03-1), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number1365970-03-1
PubChem CID66828839
Molecular formulaC38H46F4N6O9S
IUPAC name(1R,14E,18R,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3,5,7,9,11,14-hexaene-29-carboxamide
UNII (FDA)K6BUU8J72P

Computed descriptors

Molecular Weight838.9
XLogP34.6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count15
Rotatable Bond Count7
Exact Mass838.29831089
Monoisotopic Mass838.29831089
Topological Polar Surface Area204
Heavy Atom Count58

Physicochemical values on record

Solubility<0.1 to 0.3 mg/mL

Documented uses on record

    Indicated for the treatment of adult patients with acute and chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). MAVYRET is also indicated for the treatment of adult patients with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.Breast Feeding; Lactation; Milk, Human; Antiviral Agents; Protease Inhibitors

    Synonyms and trade names

    Glecaprevir; 1365970-03-1; ABT-493; Maviret; K6BUU8J72P; A-1282576.0; A-1282576; A-12825760; DTXSID901027945; glecaprevirum; RefChem:663069; DTXCID101513512; Glecaprevir [USAN]; BDBM50573891; UNII-K6BUU8J72P; MFCD30533436

    What the public record says

    Glecaprevir · CAS 1365970-03-1 · C38H46F4N6O9S. UNII K6BUU8J72P. Solubility: <0.1 to 0.3 mg/mL.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 格卡瑞韦

鲁ICP备19031700号-2